Tirzepatide is technically the combination of two different drugs: a glucagon-like peptide-1 (GLP-1) receptor agonist and a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Because of this, Tirzepatide is also known as a dual GLP-1/GIP receptor agonist. These are both hormones that your system releases after you eat
The system automatically defaults to the most conservative wavelength (Nd:YAG) after short periods of inactivity and minimizes the risk of incorrect wavelength use
[DOI] [PubMed] [Google Scholar] 283.Rodriguez P.J., Goodwin Cartwright B.M., Gratzl S., Brar R., Baker C., Gluckman T.J., Stucky N.L
So if you add up the fact that, okay, semaglutide, and I'm not picking on semaglutide, it could be any one of those synthetic incretins
Bonifacino, J